Refractive correction and patching improve VA in amblyopia

Article

Refractive correction and patching improves visual acuity in amblyopic eyes.

Refractive correction and patching improves visual acuity in amblyopic eyes, according to a paper in the Archives of Ophthalmology.

Dr Yi Pang et al., Illinois College of Optometry, Chicago, Illinois, USA, looked at 17 amblyopic children. The patients were aged between 4 and 14 years and has amblyopia linked to myopic anisometropia.

Visual acuity (VA) was evaluated at 4, 8, 12 and 16 weeks whilst all patients wore spectacles and/or contact lenses for complete refractive correction. At 16 weeks all patients underwent patching.

Mean baseline VA in amblyopic eyes improved from 0.96 logMAR to 0.84 logMAR with refractive correction and a mean of 0.71 logMAR with additional patching. The findings demonstrated an improvement of 2.59 lines when comparing baseline VA and final VA.

Final VA was linked to baseline VA, magnitude of anisometropia and the patching compliance level. The improvement in VA was linked to patient age and presence of eccentric fixation.

Overall, 88% of patients experienced an improvement of 2 lines or more and a further improvement was discovered when patching was applied to patients who underwent refractive correction.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.